TORONTO, May 31, 2017 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V: WMD ) (“ WeedMD ” or the “ Company ”) is pleased to announce it has officially begun registering patients and fulfilling orders through its online store. The WeedMD team has passionately worked towards this goal for the past three years, and looks forward to meeting the rapidly growing demand for medical cannabis. Starting pre-registration in May, the Company was fortunate enough to develop a wait list of over 1,000 patients, and plans to leverage its clinic relationships to further accelerate enrollment.
“We are extremely excited to finally open our doors to patients and begin offering access to our diverse selection of medical cannabis,” said Bruce Dawson-Scully, CEO of WeedMD. “This represents a major milestone for our Company and is only just the beginning of what we plan to achieve.”
The number of medical patients in Canada is fast approaching 200,000 - a clear demonstration of society’s faith and demand for a more natural alternative to traditional pharmaceuticals. WeedMD is keenly aware of this demand and looks forward to producing consistently high quality lab tested product to meet the needs and expectations of patients across the country.
In anticipation of beginning sales, WeedMD has produced a sizeable inventory of well over 300kg of dried product that is in its vault and ready for sale. The Company’s product offerings represent a variety of strains with varying levels of CBD and THC to address the diverse needs of medical patients in Canada. WeedMD’s line of products can be accessed online at www.weedmd.com .
WeedMD also received its license to sell cannabis plants to patients registered for home grow under the Access to Cannabis for Medical Purposes Regulations and anticipates beginning sales of cannabis starting materials within the coming week.
For more information, access our website here and our investor presentation here .
About WeedMD Inc.
WeedMD Inc. is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). WeedMD operates a 26,000 square foot, scalable production facility in Aylmer, Ontario with over four acres of property for future expansion. WeedMD is focused on providing consistent, quality medicine to the long-term care and assisted living markets in Canada through its comprehensive platform developed exclusively for that industry. WeedMD is dedicated to educating healthcare practitioners and furthering public understanding of the role medical cannabis can play as a viable alternative to prescription medication in relieving a variety of chronic medical conditions and illnesses.
Follow WeedMD On: Facebook: https://www.facebook.com/weedmd/ LinkedIn: https://www.linkedin.com/company-beta/5020743/ Twitter: https://twitter.com/WeedMD Instagram: https://www.instagram.com/weedmd/
For further information, please contact:
WeedMD Inc.
Keith Merker, Chief Financial Officer Tel: 519-765-2440 Ext. 222 Email: investor@weedmd.com
To learn more, visit us at www.weedmd.com
Forward-Looking Information
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Company's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
____________________________________________________________________________________________________________________________
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
